6505--Ra-223 Xofigo

Award Notice Posted

Solicitation number
36C25725Q0819
Agency
Awarded
to Cardinal Health 414, LLC
Set-aside
No set-aside

Opportunity facts

Contract number
36C25726D0018 Federal IDV award

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded contract 36C25726D0018 to Cardinal Health 414, LLC on October 1, 2025, for the procurement of Xofigo (Radium Ra 223 Dichloride), an FDA-approved radiopharmaceutical treatment for patients with castration-resistant prostate cancer. The award establishes a sole-source, firm-fixed price indefinite-delivery/indefinite-quantity contract for 10,000 microcuries (uCi) of Xofigo with a four-year ordering period extending from October 1, 2025, through September 30, 2029. Cardinal Health serves as the exclusive distributor for this Bayer Healthcare Pharmaceuticals proprietary product through their Access Services program, necessitating the sole-source procurement approach. While the specific contract value was not disclosed in the award notice, the procurement was processed through the VA Network Contracting Office in San Antonio, Texas, under NAICS code 325412 for pharmaceutical preparation manufacturing.

Notice text

Awarded contract 36C25726D0018 to CARDINAL HEALTH 414, LLC for unknown amount on 2025-10-01.

Files

Notice history

Notice Type Posted
This notice Award Award Notice
Xofigo Ra-223 Radium Dichloride Latest special notice Special Notice

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 See Section 11 of the Cleveland and Kent, Ohio, United States · NAICS 325412 Veterans Integrated Service Network 10 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity